These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21695775)

  • 1. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
    Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
    Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids.
    Sayed DM; el-Attar MM; Hussein AA
    Diagn Cytopathol; 2009 Jul; 37(7):498-504. PubMed ID: 19217060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies.
    Pillai V; Cibas ES; Dorfman DM
    Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings.
    Risberg B; Davidson B; Dong HP; Nesland JM; Berner A
    J Clin Pathol; 2000 Jul; 53(7):513-7. PubMed ID: 10961174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis.
    Krishan A; Ganjei-Azar P; Jorda M; Hamelik RM; Reis IM; Nadji M
    Diagn Cytopathol; 2006 Aug; 34(8):528-41. PubMed ID: 16850481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
    Kundu R; Handa U; Mohan H
    Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases.
    Davidson B; Dong HP; Berner A; Christensen J; Nielsen S; Johansen P; Bryne M; Asschenfeldt P; Risberg B
    Am J Clin Pathol; 2002 Jul; 118(1):85-92. PubMed ID: 12109861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfalls.
    Dong HP; Holth A; Berner A; Davidson B; Risberg B
    Cytometry B Clin Cytom; 2007 Sep; 72(5):332-43. PubMed ID: 17226863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry.
    Risberg B; Davidson B; Nielsen S; Dong HP; Christensen J; Johansen P; Asschenfeldt P; Berner A
    Diagn Cytopathol; 2001 Oct; 25(4):214-9. PubMed ID: 11599103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions.
    Czader M; Ali SZ
    Diagn Cytopathol; 2003 Aug; 29(2):74-8. PubMed ID: 12889043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.
    Joseph MG; Banerjee D; Harris P; Gibson S; McFadden RG
    Mod Pathol; 1995 Aug; 8(6):686-93. PubMed ID: 8532707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping.
    Sigstad E; Dong HP; Nielsen S; Berner A; Davidson B; Risberg B
    Diagn Cytopathol; 2005 Nov; 33(5):325-31. PubMed ID: 16240402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience.
    Tong LC; Ko HM; Saieg MA; Boerner S; Geddie WR; da Cunha Santos G
    Cancer Cytopathol; 2013 May; 121(5):261-70. PubMed ID: 23460311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions.
    Gioanni J; Caldani C; Zanghellini E; Mazeau C; Duplay H; Ferrua B; Schneider M
    Acta Cytol; 1991; 35(3):315-9. PubMed ID: 2042433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow immunocytochemistry of marker expression in cells from body cavity fluids.
    Krishan A; Ganjei-Azar P; Hamelik R; Sharma D; Reis I; Nadji M
    Cytometry A; 2010 Feb; 77(2):132-43. PubMed ID: 19899128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions.
    Lazcano O; Chen LM; Tsai C; Li CY; Katzmann JA; Sebo TJ; Kimlinger TK; Baker J
    Mod Pathol; 2000 Jul; 13(7):788-96. PubMed ID: 10912939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.